Sheaff Brock Investment Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$661K Buy
6,556
+266
+4% +$26.8K 0.06% 225
2024
Q4
$562K Sell
6,290
-1,409
-18% -$124K 0.05% 241
2024
Q3
$645K Buy
7,699
+2,272
+42% +$179K 0.06% 226
2024
Q2
$418K Buy
+5,427
New +$397K 0.04% 270
2023
Q1
Sell
-7,444
Closed -$344K 518
2022
Q4
$344K Buy
7,444
+44
+0.6% +$1.91K 0.03% 313
2022
Q3
$287K Hold
7,400
0.03% 342
2022
Q2
$276K Hold
7,400
0.02% 360
2022
Q1
$328K Hold
7,400
0.02% 356
2021
Q4
$314K Sell
7,400
-100
-1% -$4.2K 0.02% 366
2021
Q3
$325K Buy
+7,500
New +$332K 0.02% 352

Other funds holding BSX

Sheaff Brock Investment Advisors's BSX Position: Q1 2025 in Review

Sheaff Brock Investment Advisors increased its Boston Scientific (BSX) stake by 4.2% in Q1 2025, buying an estimated $26.8K and bringing the position to 6,556 shares worth $661K. The position accounts for 0.06% of the portfolio, ranked #225.

Sheaff Brock Investment Advisors first reported a position in BSX in Q3 2021 and has held it in 10 quarters since. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Sheaff Brock Investment Advisors held 6,556 shares of Boston Scientific worth $661K as of Q1 2025.
  • Sheaff Brock Investment Advisors bought 266 Boston Scientific shares in Q1 2025, an estimated $26.8K.
  • Boston Scientific made up 0.06% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #225 holding.
  • Sheaff Brock Investment Advisors first reported a position in Boston Scientific in Q3 2021 and has held it in 10 quarters since.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.